Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer-Reference-Cited by-同舟云学术

Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer

Published:2015-12 Issue:6 Volume:15 Page:448-457.e2
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Chung Alice,Choi Michael,Han Bing-chen,Bose Shikha,Zhang Xiao,Medina-Kauwe Lali,Sims Jessica,Murali Ramachandran,Taguiam Michael,Varda Marian,Schiff Rachel,Giuliano Armando,Cui Xiaojiang

Funder

National Institutes of Health [NIH]/National Center for Advancing Translational Science UCLA CTSI

NIH

the Avon Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference71 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers;Sjogren;J Clin Oncol,1998

3. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues;Owens;Clin Breast Cancer,2004

4. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

5. Unraveling the biologic and clinical complexities of HER2;Park;Clin Breast Cancer,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Nutrition and Cancer;Precision Nutrition;2024

2. HER2-Positive Metaplastic Breast Cancer with Resistance to Neoadjuvant Chemotherapy: Case Report;Case Reports in Oncology;2023-11-24

3. A Review and Meta-analysis on Trastuzumab Resistance in Patients with HER2+ Breast Cancer;Mini-Reviews in Medicinal Chemistry;2023-06

4. Poor histologic tumor response after adjuvant therapy in basal-like HER2-positive breast carcinoma;Pathology - Research and Practice;2021-12

5. Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes;Scientific Reports;2019-12